These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6341512)

  • 1. New approaches to the study of human dystrophic muscle cells in culture.
    Yasin R; Walsh FS; Landon DN; Thompson EJ
    J Neurol Sci; 1983 Mar; 58(3):315-34. PubMed ID: 6341512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation properties of pure populations of human dystrophic muscle cells.
    Blau HM; Webster C; Chiu CP; Guttman S; Chandler F
    Exp Cell Res; 1983 Apr; 144(2):495-503. PubMed ID: 6840225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
    Corbett AJ
    Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue culture studies of muscle disorders: Part 2. Biochemical studies, nerve-muscle culture, metabolic myopathies, and animal models.
    Witkowski JA
    Muscle Nerve; 1986 May; 9(4):283-98. PubMed ID: 3520307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.
    Miranda AF; Francke U; Bonilla E; Martucci G; Schmidt B; Salviati G; Rubin M
    Am J Med Genet; 1989 Feb; 32(2):268-73. PubMed ID: 2648829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST; Nagy B; Samaha FJ
    J Child Neurol; 1987 Jan; 2(1):17-21. PubMed ID: 3624824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen synthesis by Duchenne myogenic clones: pathogenic implications for the disease.
    Ionasescu V; Ionasescu R; Massimini G; Sandra A
    Am J Med Genet; 1982 Mar; 11(3):361-5. PubMed ID: 7081299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular protein degradation in cultures of dystrophic muscle cells and fibroblasts.
    McElligott MA; Dice JF
    Exp Cell Res; 1984 Feb; 150(2):442-51. PubMed ID: 6363108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen synthesis by Duchenne myogenic clones: pathogenic implications for the disease.
    Ionasescu V; Ionasescu R; Massimini G; Sandra A
    Birth Defects Orig Artic Ser; 1982; 18(3B):217-21. PubMed ID: 7139105
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for defective myoblasts in Duchenne muscular dystrophy.
    Blau HM; Webster C; Pavlath GK; Chiu CP
    Adv Exp Med Biol; 1985; 182():85-110. PubMed ID: 4003170
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased collagen synthesis by Duchenne myogenic clones.
    Ionasescu V; Ionasescu R
    J Neurol Sci; 1982 Apr; 54(1):79-87. PubMed ID: 7077357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of cell clones from adult human dystrophic muscle.
    Yasin R; Kundu D; Thompson EJ
    Exp Cell Res; 1982 Apr; 138(2):419-22. PubMed ID: 7075694
    [No Abstract]   [Full Text] [Related]  

  • 14. A new approach for carrier detection in Duchenne muscular dystrophy. Protein synthesis of muscle polyribosomes in vitro.
    Ionasescu V; Zellweger H; Conway TW
    Neurology; 1971 Jul; 21(7):703-9. PubMed ID: 4327312
    [No Abstract]   [Full Text] [Related]  

  • 15. Creatine kinase isoenzymes in cultured human muscle cells. I. Comparison of Duchenne muscular dystrophy with other myopathic and neurogenic disease.
    Franklin GI; Cavanagh NP; Hughes BP; Yasin R; Thompson EJ
    Clin Chim Acta; 1981 Sep; 115(2):179-89. PubMed ID: 7285363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis and muscle differentiation in a girl with severe muscular dystrophy.
    Meola G; Scarpini E; Velicogna M; Scarlato G; Larizza L; Conti AF
    J Neurol; 1986 Jun; 233(3):168-70. PubMed ID: 3723154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of fibronectin expression during human muscle differentiation.
    Meola G; Scarpini E; Velicogna M; Mottura A; Baron PL; Beretta S; Scarlato G
    Basic Appl Histochem; 1986; 30(2):153-63. PubMed ID: 3527139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase isoenzymes in cultured human muscle cells. II. A study of carrier females for Duchenne muscular dystrophy by needle and open biopsy.
    Cavanagh NP; Franklin GI; Hughes BP; Yasin R; Phillips E; van Beers G; Thompson EJ
    Clin Chim Acta; 1981 Sep; 115(2):191-8. PubMed ID: 7285364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of CK-MM is impaired in innervated and contracting cultured muscle fibers of Duchenne muscular dystrophy patients.
    Askanas V; Martinuzzi A; Engel WK; Kobayashi T; Stern LZ; Hsu JD
    Life Sci; 1987 Aug; 41(8):927-33. PubMed ID: 3613854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.